BioMarin Pharmaceutical (BMRN)
BioMarin Pharmaceutical Income from Cont. Ops: -23.97M
View BMRN Income from Cont. Ops with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
BMRN Income from Cont. Ops Rankings
| Overall | 5th percentile | 4289 of 4520 |
| Sector | 6th percentile | 482 of 513 in Healthcare |
| Industry | 12th percentile | 139 of 159 in Biotechnology |
BMRN Income from Cont. Ops Range, Past 5 Years
| Minimum | -26.74M | Dec 2011 |
| Maximum | 217.33M | Sep 2010 |
| Average | 7.592M |
You may also be interested in these BMRN related companies
BMRN News
RT @TheEquitiesRoom: Stocks trading down to 20d support: $EIX $DRI $SWI $BMC $OPTR $BMRN $HSY < nice list
about 7 days ago by 1nvestor
about 7 days ago by 1nvestor
Five Stocks Hit 52-Week Highs $RDWR $CHDN $LL $BMRN $MTH http://stks.co/3rG6 My story via @TheStreet
about 12 days ago by azendrian
about 12 days ago by azendrian
$BMRN Insider Sale: $1.5M of stock sold by Bienaime Jean Jacques between May 11, 2012 - May 14, 2012 http://stks.co/3qP6
about 12 days ago by MarketBrief
about 12 days ago by MarketBrief
$BMRN Insider Sale: $1.6M of stock sold by Davis George Eric on May 11, 2012 http://stks.co/3qOj
about 12 days ago by MarketBrief
about 12 days ago by MarketBrief
Listen to $BMRN inc. at deutsche bank ag health care conference - live at 08:00 AM, ondemand after - http://stks.co/3jp6
about 19 days ago by earningscast
about 19 days ago by earningscast
BioMarin Appoints Dan Spiegelman as Executive Vice President and Chief Financial Officer
May 08, 4:05PM Benzinga
May 08, 4:05PM Benzinga
$BMRN Insider Sale: $1.1M of stock sold by Bienaime Jean Jacques between May 1, 2012 - May 2, 2012 http://stks.co/3elV
about 25 days ago by MarketBrief
about 25 days ago by MarketBrief
BioMarin Pharmaceutical's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Apr 27, 3:10AM Seeking Alpha
Apr 27, 3:10AM Seeking Alpha
Listen to $BMRN Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3XW8
about 31 days ago by earningscast
about 31 days ago by earningscast
BioMarin Pharma (BMRN) Misses Q1 EPS by 7c; Raises FY12 Sales Guidance
Apr 26, 4:50PM Street Insider
Apr 26, 4:50PM Street Insider
$BMRN http://stks.co/3Njb $BMRN, Buy at trendline & 200 day ma support. Robust pipeline
about 41 days ago by Catalystrader
about 41 days ago by Catalystrader
UPDATE - UBS Initiates Coverage on BioMarin (BMRN) with a Buy; Accumulate on Pullback
Apr 12, 11:07AM Street Insider
Apr 12, 11:07AM Street Insider
$BMRN http://stks.co/3IgM Weekly triangle break down. Worth watch for new setup after new up correction http://stks.co/3IgN
about 47 days ago by xpertstocktrader
about 47 days ago by xpertstocktrader
$BMRN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3DE1
about 54 days ago by MarketBrief
about 54 days ago by MarketBrief
$BMRN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3C5Q
about 55 days ago by MarketBrief
about 55 days ago by MarketBrief
$BMRN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Amr
about 56 days ago by MarketBrief
about 56 days ago by MarketBrief
BioMarin Completes Enrollment for Phase 3 Trial for GALNS for the Treatment of MPS IVA
Mar 08, 9:02AM Benzinga
Mar 08, 9:02AM Benzinga
BioMarin (BMRN) Announces Completion of Enrollment for Phase 3 Study on GALNS
Mar 08, 9:02AM Street Insider
Mar 08, 9:02AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BMRN | 38.64 | +0.13 | +0.34% | 4.468B |
| BMR | 18.25 | -0.17 | -0.92% | 2.815B |
| BMO | 52.99 | -0.73 | -1.36% | 33.94B |
| BMJ | 0.93 | +0.00 | +0.00% | |
| BLC | 5.85 | -0.03 | -0.51% | 608.52M |
| BKYF | 23.80 | -0.23 | -0.96% | 177.31M |
| BKT | 7.52 | +0.00 | +0.00% | |
| BKSC | 11.64 | +0.19 | +1.66% | 51.80M |
| BKS | 17.23 | +0.19 | +1.11% | 1.037B |
| BKR | 22.63 | +0.01 | +0.04% | 215.89M |